Cell and gene therapies
-
Cell and gene get Aussie boost
- 03 Aug 2022
Three companies join CGT steering group, which is now on the hunt for a GM and Project Manager to write a manufacturing blueprint.
Read more -
Peter Mac inks US research deal
- 04 Jul 2022
The Melbourne-based cell therapies leader is working with a leading US institution on an initiative that will see more patients in cancer trials.
Read more -
Wanted: agile gene workforce
- 08 Apr 2022
Building a workforce for new and evolving technologies ‘will be challenging’, finds InGeNA’s Precision Medicine Competency Framework.
Read more -
Fourth CAR-T leaps onto MSAC
- 06 Apr 2022
Janssen’s Carvykti and a homegrown radioligand therapy are among the new options going to MSAC at its July meeting.
Read more -
Novartis, Gilead secure landmark listings
- 28 Mar 2022
Landmark listings cap off what has been an extraordinary innings for the outgoing Health Minister, who leaves a lasting legacy for patients.
Read more -
Hunt announces Genomics Australia
- 21 Mar 2022
Signature Budget investment to create a new agency in Health and ‘make Australia a global leader in the use of genomics in medicine’.
Read more -
PBAC got creative for Zolgensma
- 18 Feb 2022
The PBS limited payment options for the first gene therapy considered by the PBAC, forcing the company and department to get creative.
Read more -
Where are BMS’ CAR-Ts?
- 14 Feb 2022
While Australia has approved three CAR-Ts and a fourth is under review, BMS’ two CAR-Ts remain unseen locally. BMS gives an update.
Read more